K954778 is an FDA 510(k) clearance for the CHOLESTECH LDX SYSTEM. Classified as Ldl & Vldl Precipitation, Cholesterol Via Esterase-oxidase, Hdl (product code LBS), Class I - General Controls.
Submitted by Cholestech Corp. (Hayward, US). The FDA issued a Cleared decision on November 24, 1995 after a review of 66 days - a notably fast clearance cycle.
This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1475 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all Cholestech Corp. devices